Hebei Children's Hospital, Shijiazhuang, Hebei, China.
Epilepsia Open. 2024 Jun;9(3):891-905. doi: 10.1002/epi4.12934. Epub 2024 Apr 1.
Variants in potassium channel-related genes are one of the most important mechanisms underlying abnormal neuronal excitation and disturbances in the cellular resting membrane potential. These variants can cause different forms of epilepsy, which can seriously affect the physical and mental health of patients, especially those with refractory epilepsy or status epilepticus, which are common among pediatric patients and are potentially life-threatening. Variants in potassium ion channel-related genes have been reported in few studies; however, to our knowledge, no systematic review has been published. This study aimed to summarize the epilepsy phenotypes, functional studies, and pharmacological advances associated with different potassium channel gene variants to assist clinical practitioners and drug development teams to develop evidence-based medicine and guide research strategies. PubMed and Google Scholar were searched for relevant literature on potassium channel-related epilepsy reported in the past 5-10 years. Various common potassium ion channel gene variants can lead to heterogeneous epilepsy phenotypes, and functional effects can result from gene deletions and compound effects. Administration of select anti-seizure medications is the primary treatment for this type of epilepsy. Most patients are refractory to anti-seizure medications, and some novel anti-seizure medications have been found to improve seizures. Use of targeted drugs to correct aberrant channel function based on the type of potassium channel gene variant can be used as an evidence-based pathway to achieve precise and individualized treatment for children with epilepsy. PLAIN LANGUAGE SUMMARY: In this article, the pathogenesis and clinical characteristics of epilepsy caused by different types of potassium channel gene variants are reviewed in the light of the latest research literature at home and abroad, with the expectation of providing a certain theoretical basis for the diagnosis and treatment of children with this type of disease.
钾通道相关基因变异是异常神经元兴奋和细胞静息膜电位紊乱的最重要机制之一。这些变异可以导致不同形式的癫痫,严重影响患者的身心健康,尤其是那些患有难治性癫痫或癫痫持续状态的患者,这在儿科患者中很常见,并且可能有生命危险。已有研究报道了钾离子通道相关基因的变异,但据我们所知,尚未发表过系统评价。本研究旨在总结与不同钾通道基因突变相关的癫痫表型、功能研究和药物治疗进展,以帮助临床医生和药物研发团队制定基于证据的医学治疗方案,并指导研究策略。检索了过去 5-10 年发表的关于钾通道相关癫痫的相关文献,包括 PubMed 和 Google Scholar。各种常见的钾离子通道基因突变可导致异质性癫痫表型,功能效应可由基因缺失和复合效应引起。选择抗癫痫药物治疗是此类癫痫的主要治疗方法。大多数患者对抗癫痫药物耐药,一些新型抗癫痫药物已被发现可改善癫痫发作。根据钾通道基因突变的类型,使用靶向药物纠正异常通道功能可以作为一种基于证据的途径,为儿童癫痫的精准个体化治疗提供依据。